Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development

Qinghua Zeng, Sharbani Phukan, Yanfei Xu, Maureen Sadim, Diana S. Rosman, Michael Pennison, Jie Liao, Guang Yu Yang, Chiang Ching Huang, Laura Valle, Antonio Di Cristofano, Albert De La Chapelle, Boris Pasche*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/- mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr 1+/- mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1 +/- intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1 +/- tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer.

Original languageEnglish (US)
Pages (from-to)678-686
Number of pages9
JournalCancer Research
Issue number2
StatePublished - Jan 15 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development'. Together they form a unique fingerprint.

Cite this